MDM2 and cancer: Circ-Foxo3 was shown to interact with MDM2, p53, CDK2, and p21, resulting in cell cycle arrest [12,26], while Circ-CTNNB1 was reported to promote cancer progression by interacting with DDX3 to transactivate YY1 [37].